GlassScriptPhysician profile
Kendall L Key
NPI 1578835534
$1,107.51
in general payments reported to CMS, 2019-2025
16 companies · $77.69 in 2025
The $77.69 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $279 · 2023: $340 · 2024: $171 · 2025: $77.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.72 | 2021-2024 | |
| Allergan, INC. | $99.90 | 2022 | |
| Organogenesis INC. | $78.79 | 2022-2023 | Puraply |
| Revance Therapeutics, INC. | $68.94 | 2024-2025 | Daxxify |
| Phathom Pharmaceuticals, INC. | $64.95 | 2024 | Voquezna |
| Vertex Pharmaceuticals Incorporated | $41.11 | 2025 | |
| Genzyme Corporation | $33.24 | 2021 | |
| Olympus America INC. | $32.72 | 2023-2024 | Olympus, Olympus |
| Galderma Laboratories, L.P. | $32.15 | 2021 | |
| Pfizer INC. | $24.14 | 2021 | |
| Mentor Worldwide LLC | $21.52 | 2025 | Artoura Breast Tissue Expander |
| Lilly USA, LLC | $21.28 | 2021 | |
| Novo Nordisk INC | $19.23 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.99 | 2023 | Gattex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.